Oculis Holding AG
- OCS
- NASDAQ
- Biotechnology
- Eye Drop Therapies
- Ophthalmology
$7.26
Today −0.41%Quote Oct 19, 2026, 03:24 PM UTC
−26.95%over the last month
Max drawdown −33.1%From 1-month high −31.9%3 months −37.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$447.1M
Quote Oct 19
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$36.75
+406.2% from here
Floor
$7.11
2.1% below price
Where the price sits
9 analysts
Analyst range, low to high
$26.00$45.00
- Price $7.26
- Resistance $7.39
- Consensus $36.75
The price is right under resistance. Analysts' average target sits about 406% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about OCSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
60